HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT00265109

Study of Levetiracetam in Body Dysmorphic Disorder

This study is completed in the United States. It is testing levetiracetam for Body Dysmorphic Disorder.

Body dysmorphic disorderDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Levetiracetam may be useful for adults experiencing body dysmorphic disorder.

What would participation involve?

Participants may receive Levetiracetam, attend study visits with the research team. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with body dysmorphic disorder.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateDecember 2004
Recruitment status
Completed
Enrollment listed in the registry
17
Sponsor
Butler Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00265109
Official title
Open-Label Study of Levetiracetam in Body Dysmorphic Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00265109. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Completed

Providence

Checked Official study record (opens in a new tab)
Registry details
Registry conditions (original wording)

Body Dysmorphic Disorder

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Butler Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Levetiracetam.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as completed.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.